GENE ONLINE|News &
Opinion
Blog

Treatment
GeneOnline’s Weekly News Highlights: Aug 21-25
2023-08-28
Introducing Veopoz™: A Breakthrough Treatment for CHAPLE Disease
2023-08-28
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
Finding new pharmacological approach for neuroblastoma treatment
2018-10-16
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top